Japan
JAPANESE PRODUCTS
EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.
Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.
Europe
EUROPEAN PRODUCTS
EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.
Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.
Middle East
MIDDLE EAST PRODUCTS
EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.
Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.
China
CHINA PRODUCTS
EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.
Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.
Mexico
MEXICO PRODUCTS
EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.
Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.
Canada
CANADA PRODUCTS
EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.
Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.
United States
UNITED STATES AND GLOBAL PRODUCTS INCLUDING CHINA
EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.
Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.